| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/12/2006 | WO2006004833A2 Pyrrolotriazine kinase inhibitors |
| 01/12/2006 | WO2006004724A2 A method for preparing pyrrolotriazine compounds |
| 01/12/2006 | WO2006004703A2 PYRROLO[2,3-d]PYRIMIDINES THAT MODULATE ACK1 AND LCK ACTIVITY |
| 01/12/2006 | WO2006004702A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases |
| 01/12/2006 | WO2006004636A2 Fused heterocyclic kinase inhibitors |
| 01/12/2006 | WO2006004191A1 Pyrrolopyridazine derivatives which inhibit pde iv and tnf alfa |
| 01/12/2006 | WO2006003670A1 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof |
| 01/12/2006 | WO2006003440A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| 01/12/2006 | WO2006002895A2 Conjugates of antibody and duoarmycin derivatives as antitumor agents |
| 01/12/2006 | WO2005066174A3 Process for the preparation of carbapenem compounds |
| 01/12/2006 | US20060009638 to silicon wafer; condensation of a carbon-substituted dipyrrolemethane with a dipyrromethane-1,9-dicarbinol then oxidation; substituents provide ability for high temperature attachment to silicon at two linkages |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009477 pyridine or pyrimidine thieno(2,3-e) pyrimidine tricyclic compounds; metabotropic glutamate receptor antagonist; analgesic, anxiolytic agent: pain, migraine, urinary incontinence; neurodegenerative diseases: Alzheimer's disease |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009457 New pyridodihydropyrazinones, process for their manufacture and use thereof as medicaments |
| 01/12/2006 | US20060009456 Aryl-substituted piperazine derivatives |
| 01/12/2006 | US20060009454 Pyrrolotriazine kinase inhibitors |
| 01/12/2006 | US20060009451 10-[4-(3-Piperidin-1-yl-propoxy)-phenyl]-6,7,8,9-tetrahydro-5H-1,4,10a-triaza-cyclohepta[f]indene; 8-[4-(3-Pyrrolidin-1-yl-propoxy)-phenyl]-6,7-dihydro-5H-1,4,8a-triaza-s-indacene; 9-{4-[3-(2-Methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-5,6,7,8-tetrahydro-pyrazolo[5,1-b]quinazoline |
| 01/12/2006 | US20060009448 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | US20060009445 Tumor-inhibiting anellated azepinone derivatives |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | CA2572314A1 Pyrrolo[2,3-d]pyrimidines that modulate ack1 and lck activity |
| 01/12/2006 | CA2571680A1 Fused heterocyclic kinase inhibitors |
| 01/12/2006 | CA2570319A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases |
| 01/12/2006 | CA2570185A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/12/2006 | CA2569679A1 Conjugates of antibody and duoarmycin derivatives as antitumor agents |
| 01/12/2006 | CA2565683A1 Substituted azepine derivatives as serotonin receptor modulators |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613633A1 7-alkinylamino-triazolopyrimidines, methods for the production and use thereof to combat harmful fungi and agents containing said compounds |
| 01/11/2006 | EP1613632A1 Pyrrolo(1,2-b)pyridazine compounds and their use as crf-1 receptor antagonists |
| 01/11/2006 | EP1613631A1 Pyrrolo 1,2-b pyridazine compounds and their uses |
| 01/11/2006 | EP1613630A1 Pyrrolo'1,2-b!pyridazine compounds and their use as crf1 receptor antagonists |
| 01/11/2006 | EP1613629A1 Substituted 4-amino 1,2,4 triazolo 4,3-a quinoxalines |
| 01/11/2006 | EP1613598A2 Methods of preparing aripiprazole crystalline forms |
| 01/11/2006 | EP1613596A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 01/11/2006 | EP1613319A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/11/2006 | EP1534713B1 Alkyl-substituted pyrazolopyrimidines |
| 01/11/2006 | EP0859610B1 Ibogamine congeners |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720238A Neurologically-active compounds |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/11/2006 | CN1720223A Stabilised compositions containing polyfunctional aziridine compounds as hardening constituents |
| 01/11/2006 | CN1236438C Optical recording medium containing substituted phthalonitrile compounds and its use |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
| 01/10/2006 | US6984734 Cyclo[n]pyrroles and methods thereto |
| 01/10/2006 | US6984652 useful for the treatment or prophylaxis of bacterial infections in mammals |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/05/2006 | WO2006001944A1 Substituted azaporphyrins as fluorescence labels |
| 01/05/2006 | WO2006001511A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | WO2006001501A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 01/05/2006 | WO2006000914A1 Diazabicyclic histamine-3 receptor antagonists |
| 01/05/2006 | WO2005113553A3 Azinyl imidazoazine and azinyl carboxamide |
| 01/05/2006 | WO2005100352A8 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/05/2006 | WO2005097796A3 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| 01/05/2006 | WO2005085259A3 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 01/05/2006 | WO2004017908A3 Calcium receptor modulating compound and use thereof |
| 01/05/2006 | US20060004428 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/05/2006 | US20060004199 Process for the preparation of pure 3-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one |
| 01/05/2006 | US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 01/05/2006 | US20060004081 Cytotoxic compounds and conjugates |
| 01/05/2006 | US20060004052 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy |
| 01/05/2006 | US20060004028 Novel PARP inhibitor |
| 01/05/2006 | US20060004024 Reacting 2,4-difluorophenyl (4-piperidinyl) methanone oxime hydrochloride and 3-(2-haloethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali solution: high yeild when alkali hydroxide concentration is in the range of 20 to 40% |
| 01/05/2006 | US20060004021 Ethyl 4-{[2-(3-chlorophenyl)-2H-tetrazol-5-yl]methyl}piperazine-1-carboxylate; gastrointestinal disorders, chronic and acute pain, psychiatric and neurological disorders; obesity |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/05/2006 | US20060004008 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 01/05/2006 | US20060004006 Pyrrolotriazine kinase inhibitors |
| 01/05/2006 | US20060004004 Novel gamma secretase inhibitors |
| 01/05/2006 | US20060003995 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/05/2006 | US20060003994 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof |
| 01/05/2006 | US20060003990 Substituted azepine derivatives as serotonin receptor modulators |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003983 Photosensitizer and method for production thereof |
| 01/05/2006 | US20060003982 Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 01/05/2006 | US20060003967 Method for preparing pyrrolotriazine compounds |
| 01/05/2006 | US20060003923 Stability, reduced toxicity; covalently linked imidazole functionality |
| 01/05/2006 | US20060000388 Metaloxyphthalocyanine compounds |
| 01/05/2006 | DE102004029544A1 Formkörper enthaltend ein mikroporöses Material und mindestens ein siliciumhaltiges Bindemittel, Verfahren zu seiner Herstellung und seine Verwendung als Katalysator, insbesondere in einem Verfahren zur Herstellung von Triethylendiamin (TEDA) Molding comprising a microporous material and at least one silicon-containing binder, a process for its preparation and its use as a catalyst, in particular in a process for preparing triethylenediamine (TEDA) |
| 01/05/2006 | CA2571555A1 Diazabicyclic histamine-3 receptor antagonists |
| 01/05/2006 | CA2570578A1 Triazolopyrimidine compounds and their use for controlling pathogenic fungi |
| 01/05/2006 | CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | CA2568802A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 01/05/2006 | CA2567977A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/04/2006 | EP1612211A1 Novel carbapenem compounds |
| 01/04/2006 | EP1611889A1 Antibacterial agent and anticancer agent |
| 01/04/2006 | EP1611207A1 Fluorescent diketopyrrolopyrroles |
| 01/04/2006 | EP1611137A1 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/04/2006 | EP1611135A1 7-alkenylamino-triazolopyrimidines, method for the production thereof and use thereof in controlling harmful fungi and substances containing said triazolopyrimidines |
| 01/04/2006 | EP1611133A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1611125A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |